MaxCyte
ExPERT GTx™ Clinically validated and cGMP compliant flow electroporation. | MaxCyte
From product development to clinical trials, the GTx, with clinically validated scalable electroporation technology, is equipped to handle your most complex cellular engineering demands.
- Rapidly transfect from 75 thousand to 20 billion cells
- (Comes with) 21 CFR Part 11 enabled software as standard
- (Offers) an established regulatory path supported by an FDA Master File
- Closed, cGMP-compliant, ISO-certified and CE-marked products
Supporting Documents
Application Note
MaxCyte® Enables a cGMP-Compatible Manufacturing Process for Highly Efficient T Cell Engineering
You don't want to miss this!
To permanently access these supporting documents, fill out the short form below.
ALREADY ACCESSED THESE DOCUMENTS? SIGN IN
More Scientific Products from MaxCyte
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024 -
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
MAY 23, 2024For the Love of Digital PCR 2024
- See More
-
MAY 07, 2024Is It Anti-RNP or Anti-Sm/RNP?
-
MAY 08, 2024Expand your Multiomic Capabilities with RNAscope™
- See More
